Eden Biologics
Latest round
- Series C
Last raised
- May 2015
Total raised
- $101M
Investors
- 12
About Eden Biologics
JHL Biotech, Inc.Founded in 2012, JHL Biotech, Inc. is headquartered in Zhubei, Taiwan. The company specializes in the production of biosimilars and has undergone strategic developments to enhance its operations. Notably, JHL Biotech became publicly listed on the Taiwan Emerging Stock Board on September 17, 2015.JHL Biotech, Inc. specializes in developing biosimilar products aimed at treating various medical conditions. Their portfolio includes monoclonal antibodies and other biologics, intended to provide affordable treatment options while maintaining high standards of quality.JHL Biotech, Inc. generates revenue through the commercialization of its biosimilar products, leveraging partnerships and collaborations within the biopharmaceutical industry.JHL Biotech, Inc. plans to launch new biosimilars to broaden its product offerings, with specific timelines for release to be determined based on regulatory processes. The company aims to expand into European and North American markets, enhancing its geographical footprint by 2025.
Who invested in Eden Biologics
12 investors across 3 rounds
See all investors in Eden Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Eden Biologics
Who invested in Eden Biologics?
Eden Biologics has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eden Biologics raised?
Eden Biologics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Eden Biologics last raise money?
Eden Biologics's most recent round on record is a Series C, in May 2015.
What does Eden Biologics do?
Eden Biologics is a pharmaceuticals company.
Where is Eden Biologics headquartered?
Eden Biologics is headquartered in Zhubei, Taiwan - China.
Which VCs invest in companies like Eden Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Eden Biologics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Eden Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.